Related Experiment Video
Updated: May 31, 2026

05:18
A Protocol for Constructing a Rat Wound Model of Type 1 Diabetes
Published on: February 17, 2023
Strong diabetes.
1Warwick University, Medical School, Gibbett Hill Road, Coventry, CV4 7AL, UK.
BMJ Case Reports
|June 21, 2011
Summary
This case study reports a bodybuilder who developed diabetes due to excessive human growth hormone (hGH) misuse. This highlights the severe health risks associated with supraphysiological anabolic steroid and hGH abuse.
Area of Science:
- Endocrinology
- Sports Medicine
- Toxicology
Background:
- Professional bodybuilding often involves the misuse of anabolic steroids and human growth hormone (hGH).
- Long-term misuse of these substances can lead to severe metabolic and organ damage.
- Recreational use of supraphysiological doses of hGH poses significant health risks.
Purpose of the Study:
- To report a unique case of diabetes mellitus precipitated by supraphysiological human growth hormone misuse.
- To highlight the potential endocrine and metabolic complications of anabolic steroid and hGH abuse in athletes.
Main Methods:
- Case report of a 36-year-old male professional bodybuilder presenting with acute symptoms.
- Clinical examination, biochemical analysis (blood glucose, liver function tests, renal function), and urinalysis were performed.
- Treatment involved conservative management with insulin therapy and intravenous fluids.
Main Results:
- The patient presented with right upper quadrant pain, hepatomegaly, hyperglycemia (30.2 mmol/l), hepatitis, and acute renal failure.
- No evidence of ketonuria or acidosis was found.
- Hepatitis and hyperglycemia resolved with conservative treatment, including insulin administration.
Conclusions:
- This is the first reported case of overt diabetes mellitus directly caused by supraphysiological recreational human growth hormone misuse.
- The findings underscore the critical dangers of anabolic steroid and hGH abuse, potentially leading to severe metabolic disturbances like diabetes.
- Healthcare providers should be vigilant for endocrine and metabolic complications in individuals misusing performance-enhancing drugs.
Related Concept Videos
Diabetes: Symptoms, Diagnosis, and Complications
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Introduction
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
